Similarly, CRISPR-Cas9 mediated knockout of ataxia-telangiectasia mutated (ATM) gene, a tumor suppressor, in two human GBM cell lines such as LN18 and LN229 potentiated autophagy and increased their responsiveness to platinum treatment [58]. This evidence concerns the gene ATM and neoplasm.